FDA
-
-
-
-
-
-
-
H.C. Wainwright Reiterates Buy Rating on Agenus Inc. (AGEN)
-
-
-
-
-
-
-
Renowned GI Oncology Leader Dr. Richard Goldberg Joins Agenus as Chief Development Officer
-
-
-
-
-
-
-
Agenus Reports Second Quarter 2024 Operational and Financial Results
-
-
-
-
-
-
-
Agenus (AGEN) Announces End-of-Phase-2 Meeting Outcomes and Topline Interim Phase 2 Data for BOT/BAL in MSS Colorectal Cancer
-
-
-
-
-
-
-
Ligand and Agenus Enter Into $100 Million Royalty Financing Agreement
-
-
-
-
-
-
-
Agenus Unveils New and Updated Botensilimab Data in Colorectal, Pancreatic, Lung, Melanoma, and Sarcoma
-
-
-
-
-
-
-
ESMO GI Data: Agenus' Botensilimab/Balstilimab Combination Achieves Unprecedented Survival in Advanced Colorectal Cancer
-
325,594 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

